Sanofi CEO Paul Hudson Outlines Bold M&A and R&D Strategy for a Transformative Year Ahead
At the JP Morgan Healthcare Conference, Sanofi CEO Paul Hudson outlined the company's forward-looking strategy, emphasizing [...]
Dexcom’s Record-Breaking 2023: Major Launches, Expanded Coverage, and Exceptional Financial Growth
In 2023, a continuous glucose monitor manufacturer, Dexcom, reported a significant year marked by a major [...]
Boston Scientific to Acquire Axonics for $3.7 Billion, Expanding Urology Portfolio with Neurostimulation Therapies
Boston Scientific has announced a $3.7 billion acquisition of Axonics, a key player in neurostimulation therapies [...]
Merck Acquires Harpoon Therapeutics for $680 Million to Bolster Oncology Pipeline
Merck has agreed to acquire Harpoon Therapeutics for $680 million, significantly enhancing its cancer treatment portfolio [...]
Metagenomi Announces IPO Amid Biotech Sector’s Cooling Investor Interest
Metagenomi, a preclinical gene editing biotech, announced its initial public offering (IPO) plans, aiming to list [...]
FDA Approves Florida’s Plan to Import Prescription Drugs from Canada
The Biden administration has approved Florida Governor Ron DeSantis' plan to import certain prescription drugs from [...]
Walgreens Adopts New Drug Pricing Models and Cost-Cutting Measures under CEO Tim Wentworth’s Leadership
Walgreens Boots Alliance, under the new leadership of CEO Tim Wentworth, is preparing to adopt new [...]
Recent Developments in Healthcare and Pharmaceutical Industry: CVS Health’s Decision, Insulin Price Cap, Alzheimer’s Research, FDA Investigations, and AI Prescription Assistant Launch
CVS Health Removing Humira from Some Drug Lists: CVS Health plans to drop AbbVie’s rheumatoid arthritis [...]
Global Specialty Pharmaceutical Market Forecast: Rapid Growth to USD 1.5 Trillion by 2033
The Global Specialty Pharmaceutical Market is projected to grow from USD 68.3 billion in 2023 to [...]
Boehringer Ingelheim Forms Over $2 Billion RNA Therapy Collaboration with Ribo
Boehringer Ingelheim is partnering with Chinese biotech Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals [...]
Federal Judge Blocks IQVIA’s Acquisition of Propel Media, Citing Antitrust Concerns
A U.S. federal judge has issued a preliminary injunction at the Federal Trade Commission's (FTC) request, [...]
Inflation and Patent Expirations: Challenges and Opportunities for Pharma in 2024
Key challenges identified by a GlobalData survey include inflation, geopolitical conflict, and drug pricing pressures. Inflation [...]
Infectious Diseases in 2024: Polio Eradication, Pandemic Preparedness, and Climate Change Impacts
As we approach the fifth year of this decade, there is a cautious return to normalcy [...]
Fatal Flaw: The Tragic Case of Carlton Gautney and the Investigation into Medical Device Malfunctions
Carlton "PeeWee" Gautney Jr., a 59-year-old Alabama police dispatcher and diabetes patient, depended on a Medtronic [...]
Addressing the Opioid Crisis: The SUPPORT Act’s Bipartisan Effort in Congress
Major healthcare legislation is unlikely in an evenly divided Congress with looming elections. However, Congress is [...]
Advancements and Challenges in Real-World Data and Evidence in Healthcare
Real-world data (RWD) and real-world evidence (RWE) play significant roles in medical product development and regulatory [...]
Trinity Life Sciences Reports Promising Opportunities in China’s 2022 NRDL for Innovative Drugs
Trinity Life Sciences, a global life sciences solutions leader, reports promising opportunities for innovative drugs in [...]
CRISPR Therapeutics CMO Resigns Following Historic FDA Approval of Gene Therapy Casgevy
Six days after CRISPR Therapeutics received a significant FDA approval for its gene therapy Casgevy, developed [...]
New Government Roles to Investigate Healthcare Price-Gouging and Antitrust Issues in Biden Administration Initiative
The Biden administration is enhancing its scrutiny of healthcare price-gouging by creating new roles in three [...]
German Court Invalidates CureVac’s mRNA Vaccine Patent in Dispute with BioNTech, Impacting Stocks and Ongoing Litigations
Here's what you need to know: A German court ruled against CureVac in a patent dispute [...]
Accelerating Drug Development with AI and ML: Transforming the Future of Healthcare
The traditional drug development and approval process in the United States typically spans 10 to 12 [...]
Kaiser Permanente Awards Grants for AI and ML Research in Healthcare
The Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center, part of the [...]
NIH Working Group Proposes Major Reforms for Postdoctoral Researchers Amid Rising Industry Losses
A National Institutes of Health (NIH) working group proposed significant changes to improve the conditions for [...]
FDA Approves Merck’s Welireg for Expanded Use in Kidney Cancer, Boosting Sales Prospects
Merck’s cancer drug Welireg (belzutifan), approved in August 2021, has been making steady sales progress. Recently, [...]
U.S. Health Spending Normalizes Post-Pandemic with a Decrease in GDP Share
The summary of the recent report on U.S. health spending is as follows: Annual Health Spending [...]